A framework for prioritizing novel agents in malignant peripheral nerve sheath tumor trials: A report from the neurofibromatosis clinical trials consortium
- DOI
- 10.1093/neuonc/noag192
- Published
- 2026-08-18
- Container
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/neuonc/noag192,
title = {A framework for prioritizing novel agents in malignant peripheral nerve sheath tumor trials: A report from the neurofibromatosis clinical trials consortium},
author = {Lindy Zhang and Vanessa Eulo and Srivandana Akshintala and Amy E Armstrong and Andrea M Gross and Laura J Klesse and Kathryn M Lemberg and Varun Monga and Sameer Farouk Sait and Michael J Fisher and Brigitte C Widemann and Christine A Pratilas and Angela C Hirbe and AeRang Kim},
year = {2026},
journal = {Neuro-Oncology},
doi = {10.1093/neuonc/noag192},
url = {https://doi.org/10.1093/neuonc/noag192}
}RIS
TY - JOUR TI - A framework for prioritizing novel agents in malignant peripheral nerve sheath tumor trials: A report from the neurofibromatosis clinical trials consortium AU - Lindy Zhang AU - Vanessa Eulo AU - Srivandana Akshintala AU - Amy E Armstrong AU - Andrea M Gross AU - Laura J Klesse AU - Kathryn M Lemberg AU - Varun Monga AU - Sameer Farouk Sait AU - Michael J Fisher AU - Brigitte C Widemann AU - Christine A Pratilas AU - Angela C Hirbe AU - AeRang Kim PY - 2026 JO - Neuro-Oncology DO - 10.1093/neuonc/noag192 UR - https://doi.org/10.1093/neuonc/noag192 ER -
APA
Zhang, L., Eulo, V., Akshintala, S., Armstrong, A. E., Gross, A. M., Klesse, L. J., Lemberg, K. M., Monga, V., Sait, S. F., Fisher, M. J., Widemann, B. C., Pratilas, C. A., Hirbe, A. C., & Kim, A. (2026). A framework for prioritizing novel agents in malignant peripheral nerve sheath tumor trials: A report from the neurofibromatosis clinical trials consortium. Neuro-Oncology. https://doi.org/10.1093/neuonc/noag192
Source records
- crossref · retrieved 2026-09-26T08:14:11.561Z